NXTG.TA TLV
Nextage Therapeutics Ltd
1W: +8.4%
1M: +20.5%
3M: -11.0%
YTD: -12.0%
1Y: -62.6%
3Y: -58.3%
5Y: -93.0%
₪38.70 ($0.13)
-0.10 (-0.26%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#7
of 12
Drug Manufacturers - Specialty & Generic
Technical Signal Map
5 Bullish
0 Neutral
7 Bearish
NXTG.TA
$30M
Nextage Therapeutics Ltd
BEARISH
-42
INCR.TA
$200M
InterCure Ltd.
BULLISH
+69
REKA.TA
$130M
Rekah Pharmaceutical Industry Ltd.
BULLISH
+62
TEVA
$142B
Teva Pharmaceutical Industries Limited
BULLISH
+58
KMDA.TA
$1.5B
Kamada Ltd.
BULLISH
+35
SEMG.TA
$90M
Seach Medical Group Ltd
BULLISH
+34
OWCP
—
OWC Pharmaceutical Research Corp.
LEAN BEAR
-14
PRFX
—
PRF Technologies Ltd.
BEARISH
-31
RAPH
$30M
Raphael Pharmaceutical Inc.
BEARISH
-33
TGTR.TA
$40M
Together Pharma Ltd.
BEARISH
-74
RDHL
—
RedHill Biopharma Ltd.
BEARISH
-75
PSRX.TA
—
PsyRX CNS Bio-Tech Ltd
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| NXTG.TA Nextage Therapeutics Ltd | $30M | -2.1 | -123.3 | -21.9 | -3143.7 | 360.1 | 3 | BEARISH | -62.6 |
| INCR.TA InterCure Ltd. | $200M | -4.8 | -15.9 | -10.2 | -1.3 | -10.8 | 2 | BULLISH | 202.9 |
| REKA.TA Rekah Pharmaceutical Industry Ltd. | $130M | -8.2 | -10.7 | -1.9 | -1.8 | -2.7 | 4 | BULLISH | -2.2 |
| TEVA Teva Pharmaceutical Industries Limited | $142B | 64.0 | 9.7 | 9.3 | -13.9 | 4.1 | 7 | BULLISH | 97.1 |
| KMDA.TA Kamada Ltd. | $1.5B | 21.7 | 8.4 | 11.0 | 16.9 | 13.3 | 7 | BULLISH | -0.4 |
| SEMG.TA Seach Medical Group Ltd | $90M | 13.1 | 7.6 | 17.9 | 11.5 | -6.4 | 7 | BULLISH | 4.2 |
| OWCP OWC Pharmaceutical Research Corp. | — | -0.0 | -34.4 | 1662.7 | — | — | 2 | LEAN BEAR | 0.0 |
| PRFX PRF Technologies Ltd. | — | -0.1 | -57.8 | -88.3 | -19978.6 | 137249010644668.4 | 6 | BEARISH | -33.3 |
| RAPH Raphael Pharmaceutical Inc. | $30M | -28.5 | 59.9 | 47.0 | — | — | 2 | BEARISH | 536.4 |
| TGTR.TA Together Pharma Ltd. | $40M | -65.7 | -1.2 | 2.5 | -2.7 | 22.3 | 7 | BEARISH | -44.8 |
| RDHL RedHill Biopharma Ltd. | — | -0.2 | 428.1 | 117.9 | -101.3 | 157.6 | 6 | BEARISH | -80.2 |
| PSRX.TA PsyRX CNS Bio-Tech Ltd | — | — | — | — | — | — | — | BEARISH | — |
| NXTG.TA Nextage Therapeutics Ltd | $30M | -2.1 | -123.3 | -21.9 | -3143.7 | 360.1 | 3 | BEARISH | -62.6 |
| INCR.TA InterCure Ltd. | $200M | -4.8 | -15.9 | -10.2 | -1.3 | -10.8 | 2 | BULLISH | 202.9 |
| REKA.TA Rekah Pharmaceutical Industry Ltd. | $130M | -8.2 | -10.7 | -1.9 | -1.8 | -2.7 | 4 | BULLISH | -2.2 |
| TEVA Teva Pharmaceutical Industries Limited | $142B | 64.0 | 9.7 | 9.3 | -13.9 | 4.1 | 7 | BULLISH | 97.1 |
| KMDA.TA Kamada Ltd. | $1.5B | 21.7 | 8.4 | 11.0 | 16.9 | 13.3 | 7 | BULLISH | -0.4 |
| SEMG.TA Seach Medical Group Ltd | $90M | 13.1 | 7.6 | 17.9 | 11.5 | -6.4 | 7 | BULLISH | 4.2 |
| OWCP OWC Pharmaceutical Research Corp. | — | -0.0 | -34.4 | 1662.7 | — | — | 2 | LEAN BEAR | 0.0 |
| PRFX PRF Technologies Ltd. | — | -0.1 | -57.8 | -88.3 | -19978.6 | 137249010644668.4 | 6 | BEARISH | -33.3 |
| RAPH Raphael Pharmaceutical Inc. | $30M | -28.5 | 59.9 | 47.0 | — | — | 2 | BEARISH | 536.4 |
| TGTR.TA Together Pharma Ltd. | $40M | -65.7 | -1.2 | 2.5 | -2.7 | 22.3 | 7 | BEARISH | -44.8 |
| RDHL RedHill Biopharma Ltd. | — | -0.2 | 428.1 | 117.9 | -101.3 | 157.6 | 6 | BEARISH | -80.2 |
| PSRX.TA PsyRX CNS Bio-Tech Ltd | — | — | — | — | — | — | — | BEARISH | — |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
NXTG.TA vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F